Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 PolynovoConcordia InternationalMesoblastResverlogixOxford BioMedica
SymbolASX:PNVN/AASX:MSBTSE:RVXLON:OXB
Price Information
Current PriceA$1.55N/AA$1.40C$2.76GBX 645
52 Week RangeN/AHoldN/ABuyBuy
Analyst Ratings
Consensus RecommendationN/AHoldN/ABuyBuy
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$1.02 billionC$1.22 billion$690.70 millionC$577.27 million£495.15 million
BetaN/AN/AN/AN/AN/A
Average VolumeN/A4,0542,190,00084,9236,890,000
Sales & Book Value
Annual Revenue$8.66 millionC$569.62 million$16.46 millionN/A£66.78 million
Price / Sales118.280.0041.98N/A7.41
CashflowA$0.03 per shareN/AA$0.14 per shareC$0.04 per shareGBX 48.80 per share
Price / Cash50.005.859.8971.0013.22
Book ValueA$0.04 per shareC$6.08 per shareA$1.00 per shareC($1.08) per shareGBX 52.60 per share
Price / Book37.800.001.39N/A0.12
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSA($0.01)C$351.68A($0.18)C($0.87)GBX 10.90
Trailing P/E RatioN/A0.07N/AN/A59.17
Forward P/E RatioN/A
P/E GrowthN/AN/AA$20.71N/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A457.02%15.89%N/A118.46%
Current Ratio16.09%2.10%1.92%0.12%2.44%
Quick Ratio14.95%1.66%1.64%0.10%2.26%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees41N/A81N/A432
Shares Outstanding661.09 million48.91 million495.13 million209.15 million76.77 million
Next Earnings DateN/AN/A8/29/2019 (Estimated)9/13/2019 (Estimated)9/4/2019 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
 PolynovoConcordia InternationalMesoblastResverlogixOxford BioMedica

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel